Preoperative Prevention of Heart Failure in Noncardiac Surgery
Congestive heart failure is consistently associated with adverse outcomes, and is characterized by a twofold increase in mortality in noncardiac surgery. In this regard, developing the methods aimed to prevent and treatacute heart failure (AHF) in the intraoperative period remain a challenging probl...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2016-07-01
|
| Series: | Общая реаниматология |
| Subjects: | |
| Online Access: | https://www.reanimatology.com/rmt/article/view/1530 |
| _version_ | 1826562210724315136 |
|---|---|
| author | V. V. Likhvantsev Yu. V. Ubasev Yu. V. Skripkin T. S. Zabelina V. A. Sungurov V. V. Lomivorotov D. N. Marchenko |
| author_facet | V. V. Likhvantsev Yu. V. Ubasev Yu. V. Skripkin T. S. Zabelina V. A. Sungurov V. V. Lomivorotov D. N. Marchenko |
| author_sort | V. V. Likhvantsev |
| collection | DOAJ |
| description | Congestive heart failure is consistently associated with adverse outcomes, and is characterized by a twofold increase in mortality in noncardiac surgery. In this regard, developing the methods aimed to prevent and treatacute heart failure (AHF) in the intraoperative period remain a challenging problem.Objective. To evaluate the efficacy of preoperative levosimendan infusion in reduction both mortality and duration of treatment of elderly patients with reduced left ventricular ejection fraction in noncardiac surgery.Material and Methods. Design: Multicenter blind randomized placebocontrolled study. Patients: 81 patients operated on abdominal organs. The main endpoint of the study: The length of stay in the Intensive Care Unit (ICU) and at the hospital were chosen as the primary endpoints. The secondary endpoints of the study were 30 day and annual mortality, the rate of acute myocardial infarction and stroke.Results. Levosimendan infusion at a rate of 0,05 μg/kg/min — 0,1 μg/kg/min to patients with low left ven tricular ejection fraction just before the surgery reduced the length of stay in ICU for 2 days and required hospital stay for 3 days. NTproBNP showed the best ratio of sensitivity/specificity in predicting 30day mortality in cumulative group: AUC=0,86 (90,77 to 0,93), P<0,0001. From other indicators the most informative were the Inotropes scoring, no change or decrease of a left ventricular ejection fraction, and cardiac index.Conclusion. To reduce perioperative mortality, the intravenous infusion of levosimendan at a rate of 0,05—0,1 μg/kg/min in elderly patients with low left ventricular ejection fraction is recommened as a preoperative preparation the day before the alleged noncardiac surgery. |
| first_indexed | 2024-04-10T01:27:50Z |
| format | Article |
| id | doaj.art-02c7b34623c64776be2a3f2b626d2259 |
| institution | Directory Open Access Journal |
| issn | 1813-9779 2411-7110 |
| language | English |
| last_indexed | 2025-03-14T09:44:27Z |
| publishDate | 2016-07-01 |
| publisher | Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia |
| record_format | Article |
| series | Общая реаниматология |
| spelling | doaj.art-02c7b34623c64776be2a3f2b626d22592025-03-02T11:29:35ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102016-07-01123486110.15360/1813-9779-2016-3-48-611508Preoperative Prevention of Heart Failure in Noncardiac SurgeryV. V. Likhvantsev0Yu. V. Ubasev1Yu. V. Skripkin2T. S. Zabelina3V. A. Sungurov4V. V. Lomivorotov5D. N. Marchenko6М. F. Vladimirsky Moscow Regional Clinical Research Institute; V. A. Negovsky Research Institute of General ReanimatologyMain Clinical Military Hospital of the Federal Security Service of RussiaМ. F. Vladimirsky Moscow Regional Clinical Research Institute; V. A. Negovsky Research Institute of General ReanimatologyМ. F. Vladimirsky Moscow Regional Clinical Research InstituteMain Clinical Military Hospital of the Federal Security Service of RussiaAcademician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of RussiaState Clinical Hospital № 81, Department of Health of MoscowCongestive heart failure is consistently associated with adverse outcomes, and is characterized by a twofold increase in mortality in noncardiac surgery. In this regard, developing the methods aimed to prevent and treatacute heart failure (AHF) in the intraoperative period remain a challenging problem.Objective. To evaluate the efficacy of preoperative levosimendan infusion in reduction both mortality and duration of treatment of elderly patients with reduced left ventricular ejection fraction in noncardiac surgery.Material and Methods. Design: Multicenter blind randomized placebocontrolled study. Patients: 81 patients operated on abdominal organs. The main endpoint of the study: The length of stay in the Intensive Care Unit (ICU) and at the hospital were chosen as the primary endpoints. The secondary endpoints of the study were 30 day and annual mortality, the rate of acute myocardial infarction and stroke.Results. Levosimendan infusion at a rate of 0,05 μg/kg/min — 0,1 μg/kg/min to patients with low left ven tricular ejection fraction just before the surgery reduced the length of stay in ICU for 2 days and required hospital stay for 3 days. NTproBNP showed the best ratio of sensitivity/specificity in predicting 30day mortality in cumulative group: AUC=0,86 (90,77 to 0,93), P<0,0001. From other indicators the most informative were the Inotropes scoring, no change or decrease of a left ventricular ejection fraction, and cardiac index.Conclusion. To reduce perioperative mortality, the intravenous infusion of levosimendan at a rate of 0,05—0,1 μg/kg/min in elderly patients with low left ventricular ejection fraction is recommened as a preoperative preparation the day before the alleged noncardiac surgery.https://www.reanimatology.com/rmt/article/view/1530simdaxlevosimendanheart failurentprobnpnoncardiac surgery |
| spellingShingle | V. V. Likhvantsev Yu. V. Ubasev Yu. V. Skripkin T. S. Zabelina V. A. Sungurov V. V. Lomivorotov D. N. Marchenko Preoperative Prevention of Heart Failure in Noncardiac Surgery Общая реаниматология simdax levosimendan heart failure ntprobnp noncardiac surgery |
| title | Preoperative Prevention of Heart Failure in Noncardiac Surgery |
| title_full | Preoperative Prevention of Heart Failure in Noncardiac Surgery |
| title_fullStr | Preoperative Prevention of Heart Failure in Noncardiac Surgery |
| title_full_unstemmed | Preoperative Prevention of Heart Failure in Noncardiac Surgery |
| title_short | Preoperative Prevention of Heart Failure in Noncardiac Surgery |
| title_sort | preoperative prevention of heart failure in noncardiac surgery |
| topic | simdax levosimendan heart failure ntprobnp noncardiac surgery |
| url | https://www.reanimatology.com/rmt/article/view/1530 |
| work_keys_str_mv | AT vvlikhvantsev preoperativepreventionofheartfailureinnoncardiacsurgery AT yuvubasev preoperativepreventionofheartfailureinnoncardiacsurgery AT yuvskripkin preoperativepreventionofheartfailureinnoncardiacsurgery AT tszabelina preoperativepreventionofheartfailureinnoncardiacsurgery AT vasungurov preoperativepreventionofheartfailureinnoncardiacsurgery AT vvlomivorotov preoperativepreventionofheartfailureinnoncardiacsurgery AT dnmarchenko preoperativepreventionofheartfailureinnoncardiacsurgery |